Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
GB:AZN
Stock Latest News
Company Announcements
AstraZeneca’s CLARITY-Gastric 02 Trial Targets New Front in Stomach Cancer
14h ago
AZN
Premium
Company Announcements
AstraZeneca Files 2025 Annual Report Ahead of April 2026 AGM
20h ago
AZN
Premium
Company Announcements
AstraZeneca refreshes board as Nazneen Rahman to retire and sustainability leadership shifts
23h ago
AZN
Premium
The Fly
AIM announces planned milestones in Phase 2 trial of Ampligen, Durvalumab
2d ago
AIM
AZN
Premium
The Fly
AstraZeneca’s treatment of follicular lymphoma granted FDA orphan designation
5d ago
AZN
Premium
The Fly
AstraZeneca announces FDA approval for Calquence combination
5d ago
AZN
Premium
The Fly
AstraZeneca’s Calquence with venetoclax approved in U.S. by FDA
5d ago
AZN
Premium
Company Announcements
AstraZeneca wins U.S. nod for first fixed-duration all-oral CLL combo
5d ago
AZN
Premium
Company Announcements
AstraZeneca Targets Hidden COPD Burden in Heart Clinics: What Investors Should Watch
6d ago
AZN
Premium
The Fly
AstraZeneca marketing authorization application for Enhertu validated by EMA
6d ago
AZN
Premium
The Fly
FDA to begin requiring on clinical trial
6d ago
AZN
BMY
Premium
The Fly
FDA to begin requiring one clinical trial in drug approvals
6d ago
AZN
BMY
Premium
The Fly
AstraZeneca publishes KALOS, LOGOS trial data
12d ago
AZN
Premium
The Fly
AstraZeneca announces Phase III KALOS, LOGOS trials published on Breztri
12d ago
AZN
Premium
The Fly
Midday Fly By: January payrolls jump, Ford reports mixed Q4
14d ago
F
PM
Premium
Company Announcements
AstraZeneca Earnings Call Highlights Growth And Pipeline
14d ago
AZN
Premium
The Fly
Midday Fly By: Coca-Cola reports Q4 beat, BP suspends buyback
15d ago
U
BP
Premium
The Fly
AstraZeneca sees FY26 core EPS up low double-digit percentage
15d ago
AZN
Premium
The Fly
AstraZeneca reports Q4 core EPS $2.12 vs. $2.09 last year
15d ago
AZN
Premium
Ratings
AstraZeneca: Buy Rating Backed by Solid Execution, Attractive Valuation, and Late‑Stage Pipeline Upside
15d ago
AZN
Premium
The Fly
AstraZeneca sees FY26 core EPS increasing by low double-digit percentage
15d ago
AZN
Premium
The Fly
AstraZeneca reports Q4 core EPS $2.12, down 2% at CER
15d ago
AZN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
